Sirna gene silencing market landscape report 2025: united states and ireland stand out with 2 major m&a deals worth $54.9 billion, alnylam pharmaceuticals leads the way with 79 trials

Dublin, march 28, 2025 (globe newswire) -- the "innovation insights: sirna gene silencing" report has been added to researchandmarkets.com's offering.

ALNY Ratings Summary

ALNY Quant Ranking